Role of mitogen-activated protein kinase in the inhibition of myocardial hypertrophy by nitric oxide in renovascular hypertensive rats

Acta Physiologica Sinica

Volumn 53, Issue 1, 2001, Pages 32-36

  Lu, Wei ^a   Liu, Pei Qing ^a   Wang, Ting Huai ^a   Gong, Su Zhen ^a   Fu, Shi Gan ^a   Pan, Jing Yun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Endothelial nitric oxide (eNOS); L arginine; Mitogen activated protein kinase (MAPK); Mitogen activated protein kinase phosphatase (MKP 1); Myocardial hypertrophy; Nitric oxide (NO)

Indexed keywords

3CH134 PROTEIN; ARGININE; CELL CYCLE PROTEIN; IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; HEART MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; MALE; METABOLISM; PHYSIOLOGY; RAT; RENOVASCULAR HYPERTENSION; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE; CARDIOMYOPATHY, HYPERTROPHIC; CELL CYCLE PROTEINS; HYPERTENSION, RENOVASCULAR; IMMEDIATE-EARLY PROTEINS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0347242155     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vikstroms KL. Hypertrophy, pathology, and molecular markers of cardiac pethogenesis. Circ Res, 1998, 82: 773-778.
2. Linz W, Wiemer G, Scholkens BA. Bradykinin prevents left ventricular hypertrophy in rats. J Hypertens, 1993, 11 Suppl 5: S96-S97.
3. Hartman JC. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Ann Thorac Surg, 1995, 60: 789-792.
4. Weinberg EO, Schoen FJ, George D et al. Angiotensin converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation, 1994, 90: 1410-1422.
5. Zhan CD, Wang TH, Pan JY. The role of nitric oxide in the angiotensin II-induced hypertrophy of cardiac myocytes. Acta Physiol Sin, 1999, 51 (6): 660-666 (Chinese, English abstract).
6. Duff JL, Monia BP, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J Biol Chem, 1995, 270 (13): 7161-7166.
7. Menard J, Campbell DJ, Azizi M et al. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation, 1997, 96 (9): 3072-3078.
8. Kuwajima I, Kardon MB, Pegram BL et al. Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension. Hypertension, 1982, 4 (3 Pt 2): 113-118.
9. Goldblatt H, Haas E, Klick RL et al. The effect of main artery occlusion of one kidney on blood pressure of dogs. Proc Natl Acad Sci USA, 1976, 73 (5): 1722-1724.
10. Shapiro PS, Ahn NG. Feedback regulation of Raf-1 and motogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1). J Biol Chem, 1998, 273 (3): 1788-1793.
11. Sembrock J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Aubor Laboratory Press, 1989.
12. Green L, Wagner D, Glogowski J et al. Analysis of nitrate, nitrite, and nitrate in biological fluids. Anal Biochem, 1982, 126: 131-138.
13. Serger R, Krebs EG. The MAPK signaling cascade. FASEB J, 1995, 9 (9): 726-735.
14. Lu W, Liu PQ, Pan JY et al. The changes of MKP-1 and MAPK in myocardium of renovascular hypertensive rats. Acad J SUMS, 2000, 21 (2): 87-91 (Chinese, English abstract).
15. Wang W, Wang S, Yan L et al. Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J Biol Chem, 2000, 275 (22): 16899-16903.